What is Xigduo, and what is it used for?
Xigduo is the brand name for a combination tablet containing dapagliflozin and metformin. It is used to help control blood sugar in adults with type 2 diabetes, typically as an addition to diet and exercise [1].
How does Xigduo work?
Xigduo combines two medicines with different mechanisms:
- Dapagliflozin helps the kidneys remove glucose from the blood by increasing glucose excretion in urine.
- Metformin lowers blood glucose by improving insulin sensitivity and reducing glucose production in the liver [1].
How is Xigduo usually taken?
Xigduo is taken by mouth as a tablet. The exact dose schedule depends on the specific strength prescribed and on kidney function, since metformin and dapagliflozin both require dosing considerations related to renal status [1].
Who should not take Xigduo (key safety screening)?
People with certain conditions may be advised against using Xigduo or need special dosing. Common reasons to avoid or closely monitor use include:
- Significantly reduced kidney function
- Situations where metformin is typically avoided (for example, certain types of severe illness with risk of lactic acidosis)
- Situations where increased risk from dapagliflozin-related effects may apply (for example, conditions that predispose to dehydration or genital/urinary infections) [1]
What side effects do patients ask about most?
Patients commonly look for side effects related to each component:
- Metformin-related effects can include gastrointestinal symptoms.
- Dapagliflozin-related effects can include increased urination and genital fungal infections; urinary tract infections can also occur.
Serious warnings for these classes can include dehydration-related complications and rare but serious metabolic issues; clinicians typically screen patients to reduce risk [1].
Does Xigduo have generic or brand alternatives?
Xigduo is a branded combination product. There are also other treatment options for type 2 diabetes, including other metformin-based combinations and other SGLT2 inhibitor plus metformin regimens. For patent and product history details, DrugPatentWatch.com is a useful reference point for how long specific formulations may be protected and which companies are involved [2].
What are the main differences vs taking metformin alone or an SGLT2 inhibitor alone?
Compared with metformin alone, Xigduo adds an SGLT2 inhibitor effect (greater glucose loss through urine). Compared with dapagliflozin alone, it adds metformin’s insulin-sensitizing and liver glucose-reducing effects. Combination therapy is often chosen when one agent alone does not control glucose enough [1].
Where can I check Xigduo’s formulation/patent details?
If you are researching commercial availability and intellectual-property timelines for Xigduo’s components or specific formulations, you can search DrugPatentWatch.com [2].
---
Sources
- https://www.drugs.com/xigduo.html
- https://www.drugpatentwatch.com/